Value investing has produced some of the world’s most famous investing billionaires, including Warren Buffett, David Einhorn, and Seth Klarman, who built their fortunes by purchasing wonderful businesses at reasonable prices. But these hidden gems are few and far between - many stocks that appear cheap often stay that way because they face structural issues.
Separating the winners from the value traps is a tough challenge, and that’s where StockStory comes in. Our job is to find you high-quality companies that will stand the test of time. That said, here are three value stocks with poor fundamentals and some alternatives you should consider instead.
Fresh Del Monte Produce (FDP)
Forward P/E Ratio: 13.6x
Translating to "of the mountain" in Spanish, Fresh Del Monte (NYSE:FDP) is a leader in providing high-quality, sustainably grown fresh fruits and vegetables.
Why Are We Out on FDP?
- Sales stagnated over the last three years and signal the need for new growth strategies
- Projected sales decline of 2.9% for the next 12 months points to an even tougher demand environment ahead
- Gross margin of 8.8% is an output of its commoditized products
Fresh Del Monte Produce is trading at $42.05 per share, or 13.6x forward P/E. To fully understand why you should be careful with FDP, check out our full research report (it’s free).
Pediatrix Medical Group (MD)
Forward P/E Ratio: 10.3x
With a network of approximately 2,620 affiliated physicians caring for some of the most vulnerable patients, Pediatrix Medical Group (NYSE:MD) provides specialized physician services focused on neonatal, maternal-fetal, pediatric cardiology and other pediatric subspecialty care across 37 states.
Why Are We Cautious About MD?
- Annual sales declines of 2% for the past two years show its products and services struggled to connect with the market during this cycle
- Demand will likely be weak over the next 12 months as Wall Street expects flat revenue
- Waning returns on capital from an already weak starting point displays the inefficacy of management’s past and current investment decisions
Pediatrix Medical Group’s stock price of $23.04 implies a valuation ratio of 10.3x forward P/E. If you’re considering MD for your portfolio, see our FREE research report to learn more.
PennyMac Mortgage Investment Trust (PMT)
Forward P/B Ratio: 0.8x
Operating as a real estate investment trust since 2009 to maintain tax advantages, PennyMac Mortgage Investment Trust (NYSE:PMT) is a specialty finance company that invests in mortgage-related assets and operates a correspondent lending business.
Why Do We Think PMT Will Underperform?
- Annual sales declines of 23.1% for the past five years show its products and services struggled to connect with the market during this cycle
- Earnings per share decreased by more than its revenue over the last two years, showing each sale was less profitable
- Tangible book value per share tumbled by 5.4% annually over the last five years, showing banking sector trends are working against its favor during this cycle
At $11.95 per share, PennyMac Mortgage Investment Trust trades at 0.8x forward P/B. Read our free research report to see why you should think twice about including PMT in your portfolio.
High-Quality Stocks for All Market Conditions
ALSO WORTH WATCHING: Top 5 Momentum Stocks. The best time to own a great stock is when the market is finally noticing it. These aren't just high-quality businesses. Something is happening with them right now. Elite fundamentals meeting near-term momentum — both boxes checked at the same time.
Find out which stocks our AI platform is flagging this week. See this week's Strong Momentum stocks — FREE. Get Our Strong Momentum Stocks for Free HERE.
Stocks that made our list in 2020 include now familiar names such as Nvidia (+1,326% between June 2020 and June 2025) as well as under-the-radar businesses like the once-micro-cap company Tecnoglass (+1,754% five-year return). Find your next big winner with StockStory today.